Pages that link to "Q53229550"
Jump to navigation
Jump to search
The following pages link to Amyloid production and deposition in mutant amyloid precursor protein and presenilin-1 yeast artificial chromosome transgenic mice. (Q53229550):
Displaying 37 items.
- Focal glial activation coincides with increased BACE1 activation and precedes amyloid plaque deposition in APP[V717I] transgenic mice (Q24812365) (← links)
- APP Intracellular Domain Impairs Adult Neurogenesis in Transgenic Mice by Inducing Neuroinflammation (Q27322677) (← links)
- beta-site APP cleaving enzyme mRNA expression in APP transgenic mice: anatomical overlap with transgene expression and static levels with aging (Q28345657) (← links)
- Alzheimer disease Abeta production in the absence of S-palmitoylation-dependent targeting of BACE1 to lipid rafts (Q28504667) (← links)
- Axonal transport, amyloid precursor protein, kinesin-1, and the processing apparatus: revisited (Q28507009) (← links)
- Spatial segregation of gamma-secretase and substrates in distinct membrane domains (Q28591973) (← links)
- Short-term treatment with tolfenamic acid improves cognitive functions in Alzheimer's disease mice (Q30541295) (← links)
- Characterization of a presenilin-mediated amyloid precursor protein carboxyl-terminal fragment gamma. Evidence for distinct mechanisms involved in gamma -secretase processing of the APP and Notch1 transmembrane domains (Q30728721) (← links)
- Beta-amyloid precursor protein transgenic mice that harbor diffuse A beta deposits but do not form plaques show increased ischemic vulnerability: role of inflammation (Q30803369) (← links)
- Familial Alzheimer disease-linked presenilin 1 variants enhance production of both Abeta 1-40 and Abeta 1-42 peptides that are only partially sensitive to a potent aspartyl protease transition state inhibitor of "gamma-secretase". (Q30876784) (← links)
- Modulation of amyloid beta protein precursor processing as a means of retarding progression of Alzheimer's disease (Q33773936) (← links)
- Animal models of amyloid-beta-related pathologies in Alzheimer's disease (Q34097190) (← links)
- Size matters: use of YACs, BACs and PACs in transgenic animals (Q34220676) (← links)
- Genes, models and Alzheimer's disease (Q34240266) (← links)
- Ibuprofen attenuates oxidative damage through NOX2 inhibition in Alzheimer's disease (Q34306241) (← links)
- BAC to the future: the use of bac transgenic mice for neuroscience research (Q34457226) (← links)
- Pharmacogenomics for the treatment of dementia (Q35009345) (← links)
- Beta-amyloid mediated nitration of manganese superoxide dismutase: implication for oxidative stress in a APPNLH/NLH X PS-1P264L/P264L double knock-in mouse model of Alzheimer's disease. (Q35088324) (← links)
- Mitochondria and vascular lesions as a central target for the development of Alzheimer's disease and Alzheimer disease-like pathology in transgenic mice (Q35540388) (← links)
- Role of vascular hypoperfusion-induced oxidative stress and mitochondria failure in the pathogenesis of Azheimer disease (Q35625434) (← links)
- Presenilin transgenic mice as models of Alzheimer's disease (Q36481687) (← links)
- Neurons in Vulnerable Regions of the Alzheimer's Disease Brain Display Reduced ATM Signaling. (Q36627277) (← links)
- The value of incomplete mouse models of Alzheimer's disease (Q37083271) (← links)
- Trends in the molecular pathogenesis and clinical therapeutics of common neurodegenerative disorders (Q37249765) (← links)
- The novel squamosamide derivative FLZ enhances BDNF/TrkB/CREB signaling and inhibits neuronal apoptosis in APP/PS1 mice (Q37728184) (← links)
- Mouse models of Alzheimer's disease (Q37964886) (← links)
- Tolfenamic acid downregulates BACE1 and protects against lead-induced upregulation of Alzheimer's disease related biomarkers (Q39030830) (← links)
- Atherosclerotic lesions and mitochondria DNA deletions in brain microvessels: implication in the pathogenesis of Alzheimer's disease (Q42084556) (← links)
- Altered apolipoprotein D expression in the brain of patients with Alzheimer disease (Q43558020) (← links)
- Amyloid-associated neuron loss and gliogenesis in the neocortex of amyloid precursor protein transgenic mice. (Q43850189) (← links)
- Regulated hyperaccumulation of presenilin-1 and the "gamma-secretase" complex. Evidence for differential intramembranous processing of transmembrane subatrates (Q44488079) (← links)
- Animal and model systems for studying cystic fibrosis (Q45872321) (← links)
- DNA damage-associated oligodendrocyte degeneration precedes amyloid pathology and contributes to Alzheimer's and dementia (Q47719283) (← links)
- Alterations in beta-amyloid production and deposition in brain regions of two transgenic models (Q48242093) (← links)
- Progressive age-related impairment of cognitive behavior in APP23 transgenic mice (Q48420471) (← links)
- Transgenic mice expressing the PS1-A246E mutation: effects on spatial learning, exploration, anxiety, and motor coordination (Q48421950) (← links)
- Transgenic mouse models of Alzheimer's disease (Q74590890) (← links)